Financials
- Market Capitalization 38.29 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.17
Relación precio/flujo de caja
-7.22
Dividendos por acción
49.5
Rendimiento por dividendo, %
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4263 | INCR Intercure Ltd. - ordinary shares | 0.98 USD | -2.00% | +2.08% | +4.26% | -35.53% | 53.59 M USD | ||
| 4309 | SCYX SCYNEXIS, Inc. - Common Stock | 4.75 USD | -3.65% | +3.71% | +15.85% | +533.33% | 47.17 M USD | ||
| 4427 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.75 USD | +2.74% | -2.60% | -6.25% | -69.26% | 35.54 M USD | ||
| 4527 | CPHI China Pharma Holdings, Inc. Common Stock | 0.64 USD | +4.92% | 0.00% | -15.79% | -3.19% | 25.93 M USD |